Literature DB >> 12135122

Adequate patient selection for coronary revascularization: an overview of current methods used in daily clinical practice.

Steven A J Chamuleau1, Berthe L F van Eck-Smit, Martijn Meuwissen, Jan J Piek.   

Abstract

Widely used non-invasive stress modalities, like exercise ECG, MPS and stress-echocardiography, are the tests of first choice for the diagnosis of CAD. It has been shown in numerous studies that non-invasive assessment of perfusion abnormalities is an adequate strategy for risk stratification. Moreover, non-invasive stress testing should be performed before a diagnostic cardiac catheterization to document the presence of myocardial ischemia, as a prerequisite for coronary revascularization. Coronary angiography is the gold standard for identifying CAD; however this technique is limited in assessing functional severity of coronary narrowings ('illusion of luminology'; see also Figure 5). The recently introduced i.c. hemodynamic parameters (CFVR and FFR) can identify functional severity of specific lesions and have shown a good agreement with the results of non-invasive stress test in validation studies. Furthermore, there is accumulating evidence that it is safe to defer a PTCA procedure, based on normal FFR and CFVR values. As these indices are derived during an invasive cardiac catheterization procedure, its use is recommended during a so called 'ad hoc' PTCA setting. Furthermore, they are particularly useful for clinical decision making in patients with documented multivessel CAD, as both indices allow selective evaluation of coronary narrowings in different arteries. Revascularization procedures are costly and always have a potential risk. It is important to be aware that, using above mentioned methods, unnecessary interventions (lacking potential benefit) may be avoided.

Entities:  

Mesh:

Year:  2002        PMID: 12135122     DOI: 10.1023/a:1014372125457

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  73 in total

1.  Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology.

Authors:  S Windecker; W Maier-Rudolph; T Bonzel; G Heyndrickx; J M Lablanche; M C Morice; V Mühlberger; K L Neuhaus; F Piscione; M van den Brand; W Wijns; B Meier
Journal:  Eur Heart J       Date:  1999-04       Impact factor: 29.983

Review 2.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 3.  Coronary pressure measurement and fractional flow reserve.

Authors:  N H Pijls; B De Bruyne
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

4.  Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.

Authors:  J W Doucette; P D Corl; H M Payne; A E Flynn; M Goto; M Nassi; J Segal
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

5.  Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement.

Authors:  G J Bech; B De Bruyne; H J Bonnier; J Bartunek; W Wijns; K Peels; G R Heyndrickx; J J Koolen; N H Pijls
Journal:  J Am Coll Cardiol       Date:  1998-03-15       Impact factor: 24.094

6.  Safety of deferring angioplasty in patients with normal coronary flow velocity reserve.

Authors:  M Ferrari; B Schnell; G S Werner; H R Figulla
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

7.  Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?

Authors:  M L Geleijnse; A Elhendy; R T van Domburg; J H Cornel; R Rambaldi; A Salustri; A E Reijs; J R Roelandt; P M Fioretti
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

8.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

9.  Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.

Authors:  G V Heller; S D Herman; M I Travin; J I Baron; C Santos-Ocampo; J R McClellan
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

10.  Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire.

Authors:  B De Bruyne; N H Pijls; W J Paulus; P J Vantrimpont; S U Sys; G R Heyndrickx
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

View more
  1 in total

1.  Expected treatment benefits of percutaneous transluminal coronary angioplasty: the patient's perspective.

Authors:  O Ozkan; J Odabasi; U Ozcan
Journal:  Int J Cardiovasc Imaging       Date:  2008-02-05       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.